Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...

Real-world data support trial data on the use of lutetium-177 PSMA-617 in patients with PSMA-positive, metastatic castration-resistant prostate cancer.

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S. bladder cancer patient registry at the 2025 Genitourinary Cancers Symposium ...

Avelumab maintenance with axitinib interruption was feasible in metastatic renal cell carcinoma responders, according to ...

Some people believe they've seen mountain lions, or cougars, in the South Bend region over the years. But could they be like ...

To honor Hunter and his career, Salk will hold a symposium titled “50 Years of Rafting the River of Life” on Friday, Feb. 21.

Detailed price information for Immunitybio Inc (IBRX-Q) from The Globe and Mail including charting and trades.